Page last updated: 2024-11-05

chlorobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID7964
CHEMBL ID16200
CHEBI ID28097
SCHEMBL ID2044
MeSH IDM0098432

Synonyms (126)

Synonym
BIDD:ER0289
monochloorbenzeen
chlorobenzen
chlorbenzol
chloorbenzeen
monochlorbenzene
monochlorbenzol
nsc8433
chlorobenzene, mono-
monoclorobenzene
chlorobenzol
wln: gr
benzene, chloro-
clorobenzene
nci-c54886
nsc-8433
MCB ,
chlorbenzene
CHEBI:28097 ,
phcl
rcra waste no. u037
ccris 1357
monochlorbenzol [german]
ai3-07776
tetrosin sp
cp 27
caswell no. 183a
hsdb 55
einecs 203-628-5
un1134
epa pesticide chemical code 056504
nsc 8433
chloorbenzeen [dutch]
i p carrier t 40
clorobenzene [italian]
monochloorbenzeen [dutch]
chlorobenzenu [czech]
monoclorobenzene [italian]
chlorobenzen [polish]
inchi=1/c6h5cl/c7-6-4-2-1-3-5-6/h1-5
NCGC00091678-01
monochlorobenzene
108-90-7
chlorobenzene ,
phenyl chloride
C06990
benzene chloride
chlorobenzene, analytical standard
chlorobenzene, puriss., absolute, over molecular sieve (h2o <=0.005%), >=99.5% (gc)
chlorobenzene, anhydrous, 99.8%
C1948
CHEMBL16200
chloro-benzene
FT-0664554
S0645
AKOS000120122
A801940
chloranylbenzene
NCGC00091678-02
chlorobenzenu
chlorobenzene [un1134] [flammable liquid]
ec 203-628-5
unii-k18102wn1g
k18102wn1g ,
cas-108-90-7
dtxsid4020298 ,
NCGC00258775-01
dtxcid40298
tox21_201223
BMSE001030
STL282731
einecs 270-127-6
68411-45-0
FT-0623633
SCHEMBL2044
chlorobenzene [hsdb]
chlorobenzene [mi]
chlorobenzene [usp-rs]
chlor-benzene
1-chlorobenzene
4-chlorobenzene
chlorobezene
chloro benzene
p-chlorobenzene
3-chlorobenzene
ph-cl
chorobenzene
c6h5cl
un 1134
abluton t30
ip carrier t 40
mfcd00000530
J-002203
J-520025
chlorobenzene, anhydrous, zero2(tm), 99.8%
F0001-0183
chlorobenzene, reagentplus(r), 99%
chlorobenzene, saj special grade, >=99.5%
chlorobenzene, saj first grade, >=99.0%
chlorobenzene, puriss. p.a., acs reagent, >=99.5% (gc)
chlorobenzene, for hplc, 99.9%
chlorobenzene, acs reagent, >=99.5%
chlorobenzene, p.a., 99.5%
chlorobenzene, ar, >=99.5%
chlorobenzene, uv hplc spectroscopic, 99.5%
chlorobenzene, lr, >=99%
chlorobenzene, pharmaceutical secondary standard; certified reference material
chlorobenzene 100 microg/ml in methanol
chlorobenzene 10 microg/ml in isooctane
chlorobenzol(dot)
monochloorbenzeen(dutch)
mono-chlorobenzene
chlorobenzen(polish)
chloorbenzeen(dutch)
monoclorobenzene(italian)
chlorobenzene (acd/name 4.0)
chlorobenzene(italian)
clorobenzene(italian)
monochlorbenzol(german)
chlorobenzene acs grade
Q407768
PS-11980
AMY40791
p-chlorobenzene-
EN300-18065
benzene-13c6, chloro- (9ci)

Research Excerpts

Overview

Monochlorobenzene (MCB) is a frequently detected groundwater contaminant which is toxic and was thought to be persistent under anoxic conditions. It is a volatile organic compound that is used as a solvent in many industrial settings and has been shown to be related with irritations of the respiratory tract.

ExcerptReferenceRelevance
"Monochlorobenzene (MCB) is a frequently detected groundwater contaminant which is toxic and was thought to be persistent under anoxic conditions."( Iron oxides stimulate microbial monochlorobenzene in situ transformation in constructed wetlands and laboratory systems.
Ahlheim, J; Birkigt, J; Nijenhuis, I; Paschke, H; Richnow, HH; Schmidt, M; Wolfram, D, 2014
)
1.16
"Chlorobenzene is a volatile organic compound which is mainly used as a solvent."( In vitro models for the assessment of inflammatory and immuno-modulatory effects of the volatile organic compound chlorobenzene.
Fischäder, G; Lehmann, I; Nieber, K; Röder-Stolinski, C, 2008
)
1.28
"Chlorobenzene is a volatile organic compound that is used as a solvent in many industrial settings and has been shown to be related with irritations of the respiratory tract. "( Chlorobenzene induces the NF-kappa B and p38 MAP kinase pathways in lung epithelial cells.
Duschl, A; Eder, K; Fischäder, G; Lehmann, I; Oostingh, GJ; Röder-Stolinski, C, 2008
)
3.23
"Chlorobenzene is a volatile organic compound (VOC) that is widely used as a solvent, degreasing agent and chemical intermediate in many industrial settings. "( Chlorobenzene induces oxidative stress in human lung epithelial cells in vitro.
Feltens, R; Herberth, G; Lehmann, I; Mögel, I; Röder-Stolinski, C; Simon, JC, 2010
)
3.25
"Chlorobenzene is a widespread groundwater contaminant found at many industrial sites. "( Anaerobic conversion of chlorobenzene and benzene to CH4 and CO2 in bioaugmented microcosms.
Devine, CE; Edwards, EA; Liang, X; Nelson, J; Sherwood Lollar, B; Zinder, S, 2013
)
2.14
"Monochlorobenzene (MCB) is an important groundwater contaminant world-wide. "( Biodegradation of chlorobenzene in a constructed wetland treating contaminated groundwater.
Braeckevelt, M; Imfeld, G; Kästner, M; Kuschk, P; Mirschel, G; Richnow, HH; Rokadia, H; Stelzer, N; Weber, S, 2007
)
1.23

Effects

ExcerptReferenceRelevance
"o-Dichlorobenzene (o-DCB) has adverse effects on the liver and kidney in animals. "( Identification of urinary metabolites of human subjects exposed to o-dichlorobenzene.
Kumagai, S; Matsunaga, I, 1995
)
1.08

Toxicity

The increased toxicity mainly resulted from the conversion of chlorobenzene to more soluble toxic products and ozone production during the photodegradation process. Toxic unit (TU) and additional index (AI) were introduced to determine the outcome in combined tests.

ExcerptReferenceRelevance
" The increased toxicity mainly resulted from the conversion of chlorobenzene to more soluble toxic products and ozone production during the photodegradation process."( Chemical identification and acute biotoxicity assessment of gaseous chlorobenzene photodegradation products.
Hu, HY; Wang, C; Xi, JY, 2008
)
0.82
" The equation indicates that the toxic action is a two-step process: the pass of the chemicals through the cell membrane (described by logK(OW)) and the electron-transfer reaction of the chemicals with biomolecules (described by E(HOMO) and DeltaE)."( Toxicity of aromatic compounds to Tetrahymena estimated by microcalorimetry and QSAR.
Li, X; Liu, P; Min, X; Zhang, T, 2010
)
0.36
" Toxic unit (TU) and additional index (AI) were introduced to determine the outcome in combined tests, and the coexistence of Cu, Cd, Cr(III) and p-chlorobenzene was antagonism, and the effect of Cu, Cd, Cr(III) and o-chlorobenzene, Cu and 1,2,4-trichlorobenzene were synergism."( Joint toxicity of heavy metals and chlorobenzenes to pyriformis Tetrahymena.
Li, X; Liu, P; Lu, Y; Luo, H; Zhang, C; Zhang, T, 2014
)
0.88

Pharmacokinetics

ExcerptReferenceRelevance
"A physiologically based pharmacokinetic (PBPK) model to describe the absorption, distribution, metabolism, and elimination of chlorobenzene in rats was developed."( Development of a physiologically based pharmacokinetic model for chlorobenzene in F-344 rats.
Kania, MR; Thrall, KD; Woodstock, AD, 2004
)
0.77

Compound-Compound Interactions

A novel preconcentration method for the determination of some chlorobenzenes has been developed. The method uses a headspace solid phase microextraction (HS-SPME) based on nano-structured ZnO combined with capillary gas chromatography-mass spectrometry.

ExcerptReferenceRelevance
"A simple dispersive liquid-liquid microextraction (DLLME) method based on solidification of a floating organic drop (DLLME-SFO) technique combined with gas chromatography/electron-capture detection (GC/ECD) or gas chromatography/mass spectrometry (GC/MS) has been developed."( Dispersive liquid-liquid microextraction method based on solidification of floating organic drop combined with gas chromatography with electron-capture or mass spectrometry detection.
Huang, SD; Leong, MI, 2008
)
0.35
"In this study, a simple, novel and efficient preconcentration method for the determination of some chlorobenzenes (monochlorobenzene (MCB), three isomeric forms of dichlorobenzene (diCB), 1,3,5-trichlorobenzene (triCB) and hexachlorobenze (hexaCB)) has been developed using a headspace solid phase microextraction (HS-SPME) based on nano-structured ZnO combined with capillary gas chromatography-mass spectrometry (GC-MS)."( Optimization of headspace solid phase microextraction based on nano-structured ZnO combined with gas chromatography-mass spectrometry for preconcentration and determination of ultra-traces of chlorobenzenes in environmental samples.
Ghasemi, E; Sillanpää, M, 2014
)
0.81
"A high-performance and selective adsorbent was developed for simultaneous extraction of 6 chlorobenzenes residues in soil samples by using magnetic solid phase extraction (MSPE) combined with automated SPE followed by gas chromatography-mass spectrometry (GC-MS)."( β-cyclodextrin functionalized meso-/macroporous magnetic titanium dioxide adsorbent as extraction material combined with gas chromatography-mass spectrometry for the detection of chlorobenzenes in soil samples.
Cao, Y; Chen, S; Gan, N; Pan, M; Wu, D; Zhang, J, 2015
)
0.83

Dosage Studied

ExcerptRelevanceReference
"This study investigated the rates and pathways of gamma-hexachlorocyclohexane (gamma-HCH) dechlorination by granular zero-valent iron under different pH, iron dosage and temperature conditions."( Dechlorination of gamma-hexachlorocyclohexane by zero-valent metallic iron.
Huang, W; Peng, P; Wang, Z, 2009
)
0.35
" There were clear dose-response relations for all investigated parameters."( Excretion kinetics of 1,3-dichlorobenzene and its urinary metabolites after controlled airborne exposure in human volunteers.
Bertram, J; Christoforou, R; Esser, A; Krabbe, J; Kraus, T; Möller, M; Schettgen, T; Schweiker, M; Ziegler, P, 2023
)
1.2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
solventA liquid that can dissolve other substances (solutes) without any change in their chemical composition.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
chlorobenzene degradation67

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.85120.006038.004119,952.5996AID1159521
GLI family zinc finger 3Homo sapiens (human)Potency6.25120.000714.592883.7951AID1259368; AID1259369
AR proteinHomo sapiens (human)Potency1.51610.000221.22318,912.5098AID1259243; AID1259247
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.12590.001318.074339.8107AID926; AID938
retinoid X nuclear receptor alphaHomo sapiens (human)Potency19.21510.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.82110.001530.607315,848.9004AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency23.99040.005428.02631,258.9301AID1346982
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.02160.001024.504861.6448AID743215
thyroid stimulating hormone receptorHomo sapiens (human)Potency26.91770.001628.015177.1139AID1259385
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (31)

Assay IDTitleYearJournalArticle
AID1145387Partition coefficient, log P of the compound by HPLC analysis1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography.
AID1367492Octanol-water partition coefficient, log P of the compound2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Improvement in aqueous solubility achieved via small molecular changes.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1134602Hexane-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1331300Lipophilicity, log D of the compound at pH 7.4 by HPLC method
AID23965logD (measured by HPLC) (as log k')1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID760059Inhibition of [15N]-labeled humanized-Xenopus MDM2 (13-119 amino acids) interaction with p53 at 1 mM by NMR method2013ACS medicinal chemistry letters, Jul-11, Volume: 4, Issue:7
Deconstruction of a nutlin: dissecting the binding determinants of a potent protein-protein interaction inhibitor.
AID23443Partition coefficient (logP)1985Journal of medicinal chemistry, Mar, Volume: 28, Issue:3
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
AID1331301n-Octanol/water partition coefficient, log P of the compound by HPLC method
AID26522Partition coefficient (logD) (HPLC)1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID23961logD (measured by HPLC) (as log k')1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID1603230n-Octanol/water partition coefficient, log P of the compound by RP-HPLC analysis2019Bioorganic & medicinal chemistry, 04-15, Volume: 27, Issue:8
Small structural alterations greatly influence the membrane affinity of lipophilic ligands: Membrane interactions of bafilomycin A
AID162229Toxicity determined using Konemann's Industrial Pollutants Toxicity Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
AID760057Inhibition of Humanized-Xenopus MDM2 (13-119 amino acids) interaction with p53 at 1 to 2.5 mM by SPR analysis2013ACS medicinal chemistry letters, Jul-11, Volume: 4, Issue:7
Deconstruction of a nutlin: dissecting the binding determinants of a potent protein-protein interaction inhibitor.
AID1134601Hydrogen-bond basicity, pKHB of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID23970logD (measured by HPLC) (as log k')1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID23971logD (measured by HPLC) (as log k')1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID24226Partition coefficient (logP)1985Journal of medicinal chemistry, Sep, Volume: 28, Issue:9
Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.
AID1145366Octanol-water partition coefficient, log P of the compound1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses.
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID13312991-octanol/D2O distribution coefficient, log D of the compound at pH 7.4 by 1H NMR spectroscopic analysis
AID19262Aqueous solubility2000Bioorganic & medicinal chemistry letters, Jun-05, Volume: 10, Issue:11
Prediction of drug solubility from Monte Carlo simulations.
AID23968logD (measured by HPLC) (as log k')1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID26517Partition coefficient (logD) (HPLC)1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID23963logD (measured by HPLC) (as log k')1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID26296Partition coefficient (logD7.4)1981Journal of medicinal chemistry, Mar, Volume: 24, Issue:3
Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1149946Inhibition of alpha-chymotrypsin (unknown origin)1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Quantitative structure-activity relationship of chymotrypsin-ligand interactions.
AID1145386Partition coefficient, log P of the compound by shake-flask technique1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Direct measurement of octanol-water partition coefficients by high-pressure liquid chromatography.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (408)

TimeframeStudies, This Drug (%)All Drugs %
pre-199060 (14.71)18.7374
1990's40 (9.80)18.2507
2000's134 (32.84)29.6817
2010's155 (37.99)24.3611
2020's19 (4.66)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 104.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index104.66 (24.57)
Research Supply Index6.05 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index195.12 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (104.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.24%)5.53%
Reviews7 (1.66%)6.00%
Case Studies2 (0.48%)4.05%
Observational0 (0.00%)0.25%
Other411 (97.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]